A client presents to the healthcare setting with an episode of status epilepticus. Which of the following rescue medications would be utilized in this scenario to assist in stopping the client's seizures?
benztropine (Cogentin)
phenytoin (Dilantin)
diazepam (Valium)
ethosuximide (Zarontin)
The Correct Answer is C
A. Benztropine (Cogentin) is an anticholinergic used primarily for Parkinson's disease and does not have an effect on seizure activity.
B. Phenytoin (Dilantin) is an antiepileptic medication, but it is not typically used as a rescue medication for immediate cessation of seizures in status epilepticus; it is used for long-term management.
C. Diazepam (Valium) is a benzodiazepine that acts quickly to stop seizures and is commonly used in acute situations, including status epilepticus, due to its rapid onset of action.
D. Ethosuximide (Zarontin) is primarily used for absence seizures and is not indicated for status epilepticus.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is D
Explanation
A. Hypertension is not a direct adverse effect of febuxostat; monitoring blood pressure is important but not the primary concern with this medication.
B. Malignant hyperthermia is a rare condition typically associated with certain anesthetic agents and is not related to febuxostat.
C. Steven's Johnson Syndrome is a serious skin reaction that can occur with some medications, but it is not specifically associated with febuxostat.
D. Renal impairment is a known risk with febuxostat, and the nurse should monitor renal function closely, as gout can also be exacerbated by kidney issues and febuxostat is primarily excreted by the kidneys.
Correct Answer is B
Explanation
A. There is no established link between ciprofloxacin and endometrial cancers; this warning does not apply.
B. Ciprofloxacin has a black box warning for the risk of tendon rupture and tendinopathy, particularly in older adults and those concurrently taking corticosteroids.
C. Thromboembolic events are not specifically associated with ciprofloxacin; thus, this warning is not applicable.
D. Thrombocytopenia is a potential side effect of various medications but is not the primary concern associated with ciprofloxacin use.